Nebivolol is a blood pressure medication approved by the FDA to treat hypertension. Sold under the brand name Bystolic, it belongs to the beta-blocker family but works differently from older drugs in its class. It can be prescribed on its own or alongside other blood pressure medications.
How Nebivolol Lowers Blood Pressure
Like all beta-blockers, nebivolol slows the heart rate by blocking signals that tell the heart to beat faster and harder. But it has a second trick that most beta-blockers lack: it triggers the release of nitric oxide, a molecule that relaxes and widens blood vessels. This dual action lowers blood pressure by both calming the heart and reducing the resistance blood encounters as it flows through your arteries.
The nitric oxide effect happens through a specific pathway. Nebivolol activates a type of receptor on cells (called beta-3 receptors) that ramps up production of nitric oxide. This improves blood flow through the coronary arteries, reduces the workload on the heart, and may help protect against the kind of heart muscle thickening that develops when high blood pressure goes untreated for years.
What Makes It Different From Other Beta-Blockers
Nebivolol is the most selective beta-blocker available. It targets the receptors in the heart roughly 3.5 times more precisely than bisoprolol, which itself is considered more selective than metoprolol or atenolol. In practical terms, this means nebivolol is less likely to affect the airways, making breathing-related side effects (like wheezing or tightness) less common than with older, less selective beta-blockers.
The nitric oxide component also sets it apart metabolically. A head-to-head trial comparing nebivolol to metoprolol in patients with metabolic syndrome found meaningful differences after 12 weeks. Metoprolol significantly worsened insulin sensitivity, while nebivolol had no effect on it at all. Metoprolol also increased markers of oxidative stress and a clotting-related protein called plasminogen activator inhibitor, neither of which changed with nebivolol. For people who have both high blood pressure and concerns about blood sugar or metabolic health, this distinction matters.
Use in Heart Failure
Outside the United States, nebivolol has a broader role. European guidelines include it as a recommended beta-blocker for heart failure with reduced pumping function, based largely on a major trial called SENIORS. That study enrolled over 2,000 adults aged 70 and older with heart failure and found a 14% reduction in the combined risk of death and cardiovascular hospitalization compared to placebo over about 21 months. The benefit appeared strongest in patients with reduced heart pumping ability and in those who reached the highest dose of the medication.
The FDA has not approved nebivolol for heart failure in the U.S., so its official American indication remains hypertension only. Still, some clinicians prescribe it off-label for this purpose, particularly in older patients or those who struggle with side effects from other beta-blockers.
How Your Body Processes It
Nebivolol is broken down primarily by a liver enzyme that varies significantly between people. Most people (called extensive metabolizers) process the drug with a half-life of roughly 12 to 14 hours, meaning it clears from the body at a moderate pace. However, about 8 to 10% of the population breaks the drug down much more slowly, resulting in a half-life that can stretch to 40 or 50 hours or longer. These “poor metabolizers” end up with substantially higher drug levels in their blood from the same dose.
This genetic variation doesn’t necessarily mean the drug is unsafe for slow metabolizers, but it does mean your body’s response to a given dose can differ quite a bit from someone else’s. If you find that even a low dose produces strong effects (significant heart rate slowing, fatigue, or dizziness), your metabolism of the drug may be on the slower end.
What to Expect When Taking It
Nebivolol is taken once daily as a tablet. Most people start at a low dose, with gradual increases every one to two weeks until blood pressure reaches the target range. It can be taken with or without food. Like all beta-blockers, you should not stop it abruptly, as sudden discontinuation can cause a rebound spike in heart rate and blood pressure.
Common side effects include headache, fatigue, dizziness, and nausea. Because of its high selectivity for heart receptors and its blood vessel-relaxing properties, nebivolol tends to cause fewer of the classic beta-blocker complaints (cold hands and feet, exercise intolerance, sexual dysfunction) than older alternatives, though these can still occur. The metabolic neutrality noted in clinical trials is a genuine advantage for people with diabetes, prediabetes, or metabolic syndrome who need a beta-blocker but worry about worsening their blood sugar control.
People with severe liver problems or significant kidney impairment typically need dose adjustments, since the drug depends on the liver for breakdown and some of its byproducts are cleared through the kidneys.